HOW TO GET
NERLYNX
SUPPORT CO-PAY
CARD
REQUEST
CONTACT

This site is intended for healthcare professionals.
Prescribing Information For patients, click here.

MENU

How to get NERLYNX

NERLYNX is available through specific specialty pharmacies. To learn about reimbursement, download the form below.

Enrollment Form

View PDF »

Sample Letter of Medical Necessity

View PDF »

Specialty Pharmacy List

Download PDF
  1. AcariaHealth™
    T: (800) 511-5144 | F: (877) 541-1503 | www.acariahealth.com | Hours of operation: M-F, 8 am–10 pm (ET)
  2. Accredo® Health Group, Inc.
    T: (877) 732-3431 | F: (866) 352-3973 | www.accredo.com | Hours of operation: M-F, 8 am–11 pm (ET)
  3. Biologics, Inc.
    T: (800) 850-4306 | F: (800) 823-4506 | www.biologicsinc.com | Hours of operation: M-F, 8 am–8 pm (ET)
  4. CVS Caremark Specialty Pharmacy
    T: (844) 239-4761 | F: (855) 296-0210 | www.cvscaremarkspecialtyrx.com | Hours of operation: M-F, 8:30 am–8:30 pm (ET)
  5. Diplomat Specialty Pharmacy
    T: (877) 977-9118 | F: (800) 550-6272 | www.diplomatpharmacy.com | Hours of operation: M-F, 9 am–9 pm (ET); Sat., 9 am–5 pm (ET)
  6. Onco360®
    T: (877) 662-6633 | F: (877) 662-6355 | www.onco360.com | Hours of operation: M-F, 8 am–7 pm (ET); Sat., 9 am–2 pm (ET)

National Drug Code (NDC)

Prescribing Information

From the indication to clinical studies, read through the Prescribing Information.

View PDF »

Patient co-pay card

See how we assist patients with their NERLYNX prescription.

Learn More »

REQUEST CONTACT

Request to be contacted by a NERLYNX sales representative or a Clinical Nurse Educator (CNE)

Go »

IMPORTANT SAFETY INFORMATION

NERLYNX (neratinib) tablets, for oral use

INDICATIONS AND USAGE: NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early-stage HER2 overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.

CONTRAINDICATIONS: None

WARNINGS AND PRECAUTIONS:

ADVERSE REACTIONS: The most common adverse reactions (≥ 5%) were diarrhea, nausea, abdominal pain, fatigue, vomiting, rash, stomatitis, decreased appetite, muscle spasms, dyspepsia, AST or ALT increase, nail disorder, dry skin, abdominal distention, epistaxis, weight decreased and urinary tract infection.

To report SUSPECTED ADVERSE REACTIONS, contact Puma Biotechnology, Inc. at 1-844-NERLYNX (1-844-637-5969) and www.NERLYNX.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DRUG INTERACTIONS:

USE IN SPECIFIC POPULATIONS:

For Full Prescribing Information, please click here.